The total number of shares in Flerie AB (publ) (the “Company”) as of 30 June 2026 amounts to 86,697,702, all of which are ordinary shares. There are no issued shares of series C. The total number of votes in the Company as of 30 June 2026 amounts to 86,697,702.
The change in the number of shares and votes in the Company is due to the cancellation of 8,412,578 ordinary shares, as resolved by the extraordinary general meeting on 15 June 2026. The cancellation is attributable to the fact that the Company's principal shareholder, Thomas Eldered, has returned, without consideration, the ordinary shares that his wholly owned companies T&M Förvaltning AB and T&M Participation AB were allotted through the bonus issue resolved by the annual general meeting on 26 March 2026.
For more information, please contact:
Ted Fjällman, CEO of Flerie
E-mail: ir@flerie.com
Telephone: +46 (0)76 600 89 26
About Flerie
Flerie is an active long-term life science investor, with a broad and diversified portfolio of innovative companies based on pioneering science. We invest in product development and commercial growth opportunities globally alongside other leading investors, focusing predominantly on private companies that are otherwise difficult to access. Flerie’s active ownership model, broad network and resources support and accelerate the development of the portfolio projects, creating value for shareholders. Flerie AB’s ordinary share is listed on Nasdaq Stockholm with the ticker FLERIE. For further information, please visit www.flerie.com.